How to Get Xospata (Gilteritinib) Covered by Cigna in North Carolina: Complete Prior Authorization and Appeals Guide
Quick Answer: Getting Xospata (Gilteritinib) Covered by Cigna in North Carolina
Xospata requires prior authorization from Cigna for relapsed/refractory AML with confirmed FLT3 mutation. Your fastest path: 1) Verify FLT3 test results (ITD or TKD via FDA-approved assay), 2) Have your hematologist/oncologist submit PA via Cigna portal with